Literature DB >> 22955889

[Aneurysmal subarachnoid hemorrhage].

P Kellner1, D Stoevesandt, J Soukup, M Bucher, C Raspé.   

Abstract

Acute subarachnoid hemorrhage (SAH) is a severe and acute life-threatening cerebrovascular disease. Approximately 80% of all acute non-traumatic SAHs are the result of a ruptured cerebrovascular aneurysm. Despite advances in diagnosis and treatment a high morbidity and mortality still exists. Apart from the primary cerebral damage there are also secondary complications, such as vasospasm, rebleeding, hydrocephalus, cerebral edema or hydrocephalus. For an appropriate therapy an understanding of the extensive pathophysiology, the options in diagnostics and therapy and the complications of the disease are essential. Anesthesiologists are decisively involved in the therapy of the primary and secondary damages and subsequently in the outcome as well. This article provides an overview of the perioperative and intensive care management of patients with SAH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22955889     DOI: 10.1007/s00101-012-2077-2

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  152 in total

Review 1.  External ventricular drainage for intraventricular hemorrhage.

Authors:  Mahua Dey; Jennifer Jaffe; Agnieszka Stadnik; Issam A Awad
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

2.  Decompressive hemicraniectomy for the treatment of intractable intracranial hypertension after aneurysmal subarachnoid hemorrhage.

Authors:  Clemens M Schirmer; Daniel A Hoit; Adel M Malek
Journal:  Stroke       Date:  2007-02-01       Impact factor: 7.914

3.  Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study.

Authors:  Thomas Westermaier; Christian Stetter; Giles H Vince; Mirko Pham; Jose Perez Tejon; Jörg Eriskat; Ekkehard Kunze; Cordula Matthies; Ralf-Ingo Ernestus; Laszlo Solymosi; Klaus Roosen
Journal:  Crit Care Med       Date:  2010-05       Impact factor: 7.598

4.  Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.

Authors:  Peter Vajkoczy; Bernhard Meyer; Stefan Weidauer; Andreas Raabe; Claudius Thome; Florian Ringel; Volker Breu; Peter Schmiedek
Journal:  J Neurosurg       Date:  2005-07       Impact factor: 5.115

5.  Systemic glucose and brain energy metabolism after subarachnoid hemorrhage.

Authors:  Raimund Helbok; J Michael Schmidt; Pedro Kurtz; Khalid A Hanafy; Luis Fernandez; R Morgan Stuart; Mary Presciutti; Noeleen D Ostapkovich; E Sander Connolly; Kiwon Lee; Neeraj Badjatia; Stephan A Mayer; Jan Claassen
Journal:  Neurocrit Care       Date:  2010-06       Impact factor: 3.210

6.  Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage.

Authors:  Paul Klimo; John R W Kestle; Joel D MacDonald; Richard H Schmidt
Journal:  J Neurosurg       Date:  2004-02       Impact factor: 5.115

7.  The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage.

Authors:  Mark Sherlock; Eoin O'Sullivan; Amar Agha; Lucy Ann Behan; Danny Rawluk; Paul Brennan; William Tormey; Christopher J Thompson
Journal:  Clin Endocrinol (Oxf)       Date:  2006-03       Impact factor: 3.478

8.  Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery.

Authors:  S Scheingraber; M Rehm; C Sehmisch; U Finsterer
Journal:  Anesthesiology       Date:  1999-05       Impact factor: 7.892

9.  Mortality rates after subarachnoid hemorrhage: variations according to hospital case volume in 18 states.

Authors:  DeWitte T Cross; David L Tirschwell; Mary Ann Clark; Dan Tuden; Colin P Derdeyn; Christopher J Moran; Ralph G Dacey
Journal:  J Neurosurg       Date:  2003-11       Impact factor: 5.115

Review 10.  Antiplatelet therapy for aneurysmal subarachnoid haemorrhage.

Authors:  S M Dorhout Mees; W M van den Bergh; A Algra; G J E Rinkel
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17
View more
  1 in total

1.  The Nimodipine-Sparing Effect of Perioperative Dexmedetomidine Infusion During Aneurysmal Subarachnoid Hemorrhage: A Prospective, Randomized, Controlled Trial.

Authors:  Chunguang Ren; Jian Gao; Guang Jun Xu; Huiying Xu; Guoying Liu; Lei Liu; Liyong Zhang; Jun-Li Cao; Zongwang Zhang
Journal:  Front Pharmacol       Date:  2019-08-02       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.